West Oak Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

West Oak Capital’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-147	Closed	-$81	–	278
2025 Q2	$81	Hold	147	–	–	﹤0.01%	251
2025 Q1	$104	Hold	147	–	–	﹤0.01%	240
2024 Q4	$97K	Hold	147	–	–	﹤0.01%	247
2024 Q3	$103	Hold	147	–	–	﹤0.01%	244
2024 Q2	$12.1K	Hold	147	–	–	﹤0.01%	243
2024 Q1	$13K	Hold	147	–	–	0.01%	237
2023 Q4	$14K	Hold	147	–	–	0.01%	230
2023 Q3	$13K	Hold	147	–	–	0.01%	228
2023 Q2	$12.7K	Hold	147	–	–	0.01%	236
2023 Q1	$14.3K	Hold	147	–	–	0.01%	224
2022 Q4	$15K	Hold	147	–	–	0.01%	197
2022 Q3	$12K	Hold	147	–	–	0.01%	224
2022 Q2	$12K	Hold	147	–	–	0.01%	231
2022 Q1	$11K	Hold	147	–	–	0.01%	255
2021 Q4	$13K	Hold	147	–	–	﹤0.01%	253
2021 Q3	$11K	Hold	147	–	–	﹤0.01%	275
2021 Q2	$12K	Hold	147	–	–	﹤0.01%	266
2021 Q1	$11K	Hold	147	–	–	﹤0.01%	268
2020 Q4	$13K	Hold	147	–	–	0.01%	245
2020 Q3	$11K	Hold	147	–	–	0.01%	229
2020 Q2	$18K	Hold	147	–	–	0.01%	208
2020 Q1	$12K	Hold	147	–	–	0.01%	216
2019 Q4	$12K	Hold	147	–	–	0.01%	230
2019 Q3	$10K	Hold	147	–	–	0.01%	243
2019 Q2	$13K	Hold	147	–	–	0.01%	240
2019 Q1	$13K	Hold	147	–	–	0.01%	230
2018 Q4	$12.5K	Hold	147	–	–	0.01%	234
2018 Q3	$14.3K	Hold	147	–	–	0.01%	245
2018 Q2	$13.8K	Hold	147	–	–	0.01%	244
2018 Q1	$11.9K	Hold	147	–	–	0.01%	262
2017 Q4	$13.1K	Hold	147	–	–	0.01%	235
2017 Q3	$13.7K	Hold	147	–	–	0.01%	260
2017 Q2	$13.4K	Buy	+147	New	+$13.4K	0.01%	270

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

West Oak Capital's BMRN Position: Q3 2025 in Review

West Oak Capital sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2025, closing a stake of 147 shares — an estimated $81 sold.

West Oak Capital first reported a position in BMRN in Q2 2017 and held it in 33 quarters. The position peaked at $97K in Q4 2024. 577 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

West Oak Capital reported no remaining BioMarin Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
West Oak Capital sold 147 BioMarin Pharmaceuticals shares in Q3 2025, an estimated $81.
West Oak Capital first reported a position in BioMarin Pharmaceuticals in Q2 2017 and held it in 33 quarters.
West Oak Capital's BioMarin Pharmaceuticals position peaked at $97K in Q4 2024.
577 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on West Oak Capital's 13F filing for Q3 2025, filed 3 Oct 2025.